Morbi et tellus imperdiet, aliquam nulla sed, dapibus erat. Aenean dapibus sem non purus venenatis vulputate. Donec accumsan eleifend blandit. Nullam auctor ligula

Get In Touch

Quick Email
info.help@gmail.com
  • Home |
  • Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies

Eli Lilly inks $2.88B Merida buyout for autoimmune drugs against rogue antibodies

  • August 31, 2026

Eli Lilly has struck a deal to acquire Merida Biosciences for up to $2.875 billion, establishing a beachhead in efforts to treat disease through the selective degradation of pathogenic autoantibodies.

Leave A Comment

Fields (*) Mark are Required